Monarch Biosciences

Developer of locally deliverable cell therapies

placeLos Angeles, California, United States calendar_todayFounded 2011 language monarch-bio.com

Innovation

15 patent families (13 granted) — focus: Human necessities; filing pace slowing. Cited 739 times.

YearFilings
20181
20197
20206
20218
20227
20233
20241
20253
20261

Investor mix

2 investors on record; lead investors include Checkmate Capital.

Investor typeCountShare
Private equity150%
Accelerator & incubator150%
Coming soon